{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:48:34Z","timestamp":1791884914219,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bvth.2026.100207","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:26:48Z","timestamp":1788452808000},"page":"100207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world thrombotic and survival outcomes with ESAs in cancer-related anemia"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3222-9454","authenticated-orcid":false,"given":"Rafi","family":"Aibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-4630","authenticated-orcid":false,"given":"Jennifer E.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniyal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9210-2191","authenticated-orcid":false,"given":"Amir","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 5","key":"10.1016\/j.bvth.2026.100207_bib1","doi-asserted-by":"crossref","first-page":"v244","DOI":"10.1093\/annonc\/mdq202","article-title":"Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO clinical practice guidelines for use","volume":"21","author":"Schrijvers","year":"2010","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.bvth.2026.100207_bib2","article-title":"Erythropoietin or darbepoetin for patients with cancer","volume":"12","author":"Tonia","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bvth.2026.100207_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.23628","article-title":"Diagnosis and treatment of cancer-related anemia","volume":"89","author":"Gilreath","year":"2014","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.bvth.2026.100207_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djj189","article-title":"Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients","volume":"98","author":"Bohlius","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.bvth.2026.100207_bib6","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.bvth.2026.100207_bib7","article-title":"Efficacy and cardiovascular adverse effects of erythropoiesis stimulating agents in the treatment of cancer-related anemia: a systematic review of randomized controlled trials","volume":"13","author":"Gergal Gopalkrishna Rao","year":"2021","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.bvth.2026.100207_bib8","first-page":"1","article-title":"Cancer-related venous thromboembolism: insight into underestimated risk factors","volume":"12","author":"Falanga","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bvth.2026.100207_bib9","first-page":"1","article-title":"Pharmacological cancer treatment and venous thromboembolism risk","volume":"12","author":"Navi","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.bvth.2026.100207_bib10","first-page":"1","article-title":"Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors)","volume":"11","author":"Khorana","year":"2003","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.bvth.2026.100207_bib11","first-page":"1","article-title":"Erythropoietic agents in chemotherapy-induced anemia: a review of recent therapeutic progress, issues, and concerns","volume":"10","author":"Spivak","year":"2005","journal-title":"The Oncologist"},{"issue":"suppl 2","key":"10.1016\/j.bvth.2026.100207_bib12","first-page":"1","article-title":"Erythropoietin in cancer-related anemia","volume":"5","author":"Ludwig","year":"2000","journal-title":"The Oncologist"},{"issue":"suppl 2","key":"10.1016\/j.bvth.2026.100207_bib13","first-page":"1","article-title":"Recombinant human erythropoietin in the treatment of cancer-related anaemia","volume":"8","author":"Henry","year":"1997","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100207_bib14","first-page":"1","article-title":"Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions","volume":"6","author":"Bennett","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.bvth.2026.100207_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djj189","article-title":"Erythropoiesis-stimulating agents in the management of cancer patients with anemia: a meta-analysis","volume":"98","author":"Bohlius","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"10.1016\/j.bvth.2026.100207_bib16","first-page":"1","article-title":"Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis","volume":"26","author":"Bennett","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bvth.2026.100207_bib17","first-page":"1","article-title":"Risk of venous thromboembolism with erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis of randomized controlled trials","volume":"25","author":"Gao","year":"2014","journal-title":"Ann Oncol"},{"issue":"25","key":"10.1016\/j.bvth.2026.100207_bib18","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study","volume":"23","author":"Leyland-Jones","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.bvth.2026.100207_bib19","first-page":"1","article-title":"Adjuvant darbepoetin alfa in primary breast cancer: final results of the WSG-ARA trial","volume":"29","author":"Untch","year":"2011","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.bvth.2026.100207_bib20","first-page":"1","article-title":"Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"21","author":"Henke","year":"2003","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.bvth.2026.100207_bib21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab","volume":"99","author":"Scappaticci","year":"2007","journal-title":"J Natl Cancer Inst"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:25:44Z","timestamp":1791883544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950327226000720"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100207","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world thrombotic and survival outcomes with ESAs in cancer-related anemia","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100207"}}